Graham Capital Management, L.P. Novo Cure LTD Transaction History
Graham Capital Management, L.P.
- $5.08 Billion
- Q4 2024
A detailed history of Graham Capital Management, L.P. transactions in Novo Cure LTD stock. As of the latest transaction made, Graham Capital Management, L.P. holds 21,709 shares of NVCR stock, worth $423,108. This represents 0.01% of its overall portfolio holdings.
Number of Shares
21,709
Previous 52,945
59.0%
Holding current value
$423,108
Previous $827,000
21.89%
% of portfolio
0.01%
Previous 0.02%
Shares
7 transactions
Others Institutions Holding NVCR
# of Institutions
290Shares Held
75.6MCall Options Held
1.77MPut Options Held
538K-
Black Rock Inc. New York, NY12.1MShares$236 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$230 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA8.87MShares$173 Million0.05% of portfolio
-
Capital World Investors Los Angeles, CA4.82MShares$93.9 Million0.02% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.74MShares$53.4 Million5.68% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $2.05B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...